Clinical Trials
5 trialsNCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT00982514 2012-09-12
Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008
Oslo University Hospital
Unknown
NCT00378781 2012-02-24
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00004875 2011-02-21
Heparin or Enoxaparin in Patients With Cancer
Northwestern University
Completed